Immunovant, Inc. (IMVT) Earnings
NASDAQ·Healthcare·Biotechnology
$30.53
+7.33%
Mkt Cap $6.31B
EPS — Estimate vs Actual
Mkt Cap
$6.31B
P/E
—
Fwd P/E
—
P/S
—
Rev TTM
—
EPS TTM
-$2.78
NASDAQ·Healthcare·Biotechnology
$30.53
+7.33%
Mkt Cap $6.31B
Mkt Cap
$6.31B
P/E
—
Fwd P/E
—
P/S
—
Rev TTM
—
EPS TTM
-$2.78